Recent research suggests that GLP-1 drugs may have promise in the treatment of cardiovascular disease, neurodegenerative disorders, and drug and alcohol addiction, among others
doi: 10.1016/j.sleh.2023.07.016 40 SchettiniMASPassosRKoikeBDV
Supporting Weight Loss: Due to their appetite-suppressing effects, GLP-1 medications have been shown to support weight loss in individuals with type 2 diabetes and obesity
Food and Drug Administration in 2024 as a warning ( Retrospective cohort study of obese or T2DM patients reported cases showing no linkor even improvementin suicidality, with reduced risk of sudden or recurrent suicidal thoughts ( 5 State of the art and future directions No clear causal mechanism linking GLP-1 RA use to suicidality has been established
brand-name Wegovy: $1,2001,400/month)
The total weekly medication remains identical, but the delivery pattern changes dramatically